283 related articles for article (PubMed ID: 10064831)
1. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.
Oh JD; Vaughan CL; Chase TN
Brain Res; 1999 Mar; 821(2):433-42. PubMed ID: 10064831
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration.
Oh JD; Russell DS; Vaughan CL; Chase TN
Brain Res; 1998 Nov; 813(1):150-9. PubMed ID: 9824689
[TBL] [Abstract][Full Text] [Related]
3. Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats.
Ba M; Kong M; Yang H; Ma G; Lu G; Chen S; Liu Z
Neurochem Res; 2006 Nov; 31(11):1337-47. PubMed ID: 17053970
[TBL] [Abstract][Full Text] [Related]
4. Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism.
Picconi B; Gardoni F; Centonze D; Mauceri D; Cenci MA; Bernardi G; Calabresi P; Di Luca M
J Neurosci; 2004 Jun; 24(23):5283-91. PubMed ID: 15190099
[TBL] [Abstract][Full Text] [Related]
5. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
Cole DG; Kobierski LA; Konradi C; Hyman SE
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
[TBL] [Abstract][Full Text] [Related]
6. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.
Dunah AW; Wang Y; Yasuda RP; Kameyama K; Huganir RL; Wolfe BB; Standaert DG
Mol Pharmacol; 2000 Feb; 57(2):342-52. PubMed ID: 10648644
[TBL] [Abstract][Full Text] [Related]
7. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
[TBL] [Abstract][Full Text] [Related]
9. NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.
Wessell RH; Ahmed SM; Menniti FS; Dunbar GL; Chase TN; Oh JD
Neuropharmacology; 2004 Aug; 47(2):184-94. PubMed ID: 15223297
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
11. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats.
Cai G; Zhen X; Uryu K; Friedman E
J Neurosci; 2000 Mar; 20(5):1849-57. PubMed ID: 10684886
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
Nash JE; Brotchie JM
Mov Disord; 2002 May; 17(3):455-66. PubMed ID: 12112191
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.
Dunah AW; Standaert DG
J Neurosci; 2001 Aug; 21(15):5546-58. PubMed ID: 11466426
[TBL] [Abstract][Full Text] [Related]
15. MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior.
Boldry RC; Papa SM; Kask AM; Chase TN
Brain Res; 1995 Sep; 692(1-2):259-64. PubMed ID: 8548312
[TBL] [Abstract][Full Text] [Related]
16. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Papadeas ST; Blake BL; Knapp DJ; Breese GR
J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
18. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
Pollack AE; Strauss JB
Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats.
Oh JD; Chartisathian K; Ahmed SM; Chase TN
J Neurosci Res; 2003 Jun; 72(6):768-80. PubMed ID: 12774317
[TBL] [Abstract][Full Text] [Related]
20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
